Elamipretide (SS-31) studies: 372 papers with results
Page 7 of 8
- Oral Colon- and Mitochondria-Targeted Nanoparticles Alleviate Ulcerative Colitis by Reeducating Macrophage Polarization via SIRT3/FOXO3a-Mediated Mitochondrial Restoration.
Mei R · Journal of gastroenterology and hepatology · 2026
Not a test of Elamipretide (SS-31) alone · 13 results
- Light-Activated Gold-Selenium Core-Shell Nanocomposites with NIR-II Photoacoustic Imaging Performances for Heart-Targeted Repair.
Sun Y · ACS nano · 2022
Not a test of Elamipretide (SS-31) alone · 12 results
- HA/CD44-SS31 Mitochondrial Targeting of Manganese Oxide Nanozymes for Ischemia-Reperfusion-Induced Acute Kidney Injury Therapy.
Lin Z · ACS nano · 2026
Not a test of Elamipretide (SS-31) alone · 12 results
- Mitochondrial-targeting and NIR-responsive Mn3O4@PDA@Pd-SS31 nanozymes reduce oxidative stress and reverse mitochondrial dysfunction to alleviate osteoarthritis.
Li Y · Biomaterials · 2024
Not a test of Elamipretide (SS-31) alone · 11 results
- Comprehensive dry eye therapy: overcoming ocular surface barrier and combating inflammation, oxidation, and mitochondrial damage.
Xia Y · Journal of nanobiotechnology · 2024
Not a test of Elamipretide (SS-31) alone · 10 results
- Biomimetic nanoparticles with enhanced rapamycin delivery for autism spectrum disorder treatment via autophagy activation and oxidative stress modulation.
Miao C · Theranostics · 2024
Not a test of Elamipretide (SS-31) alone · 10 results
- SS-31@Fer-1 Alleviates ferroptosis in hypoxia/reoxygenation cardiomyocytes via mitochondrial targeting.
Zheng H · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
Not a test of Elamipretide (SS-31) alone · 10 results
- Near infrared enhanced palladium loaded siraitia grosvenorii carbon dots amplify mitophagy for acute lung injury immunotherapy.
Zhang J · Bioactive materials · 2026
Not a test of Elamipretide (SS-31) alone · 9 results
- Copper nanoregulator with organelle-level precision reprograms COMMD1-Mediated copper homeostasis for myocardial infarction repair.
Zang Q · Biomaterials · 2026
Not a test of Elamipretide (SS-31) alone · 9 results
- Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets TREM2 to Mitigate Post-ischemic Brain Injury in Mice.
Yang Q · Neurochemical research · 2026
Not a test of Elamipretide (SS-31) alone · 23 results
- NIR-Responsive Mitochondrial-Targeted Nanozymes With Built-In Antibacterial Function for Safe Osteoarthritis Therapy.
Cui J · Advanced healthcare materials · 2026
Not a test of Elamipretide (SS-31) alone · 9 results
- Mitochondria-targeted peptides prevent on contrast-induced acute kidney injury in the rats with hypercholesterolemia.
Duan SB · Renal failure · 2013
Not a test of Elamipretide (SS-31) alone · 8 results
- Peptide coacervate-Prussian blue hybrid supraparticle-tailored scaffolds for revitalizing diabetic heart valve regeneration via multiplex oxidative stress regulation.
Fan Y · Biomaterials · 2026
Not a test of Elamipretide (SS-31) alone · 8 results
- Mitochondria-targeted nanozyme hydrogel remodels the microenvironment to enhance bone regeneration in diabetes-associated periodontitis.
Yan J · Journal of nanobiotechnology · 2026
Not a test of Elamipretide (SS-31) alone · 8 results
- Mitochondria-targeted MXene-based nanozymes promote mitophagy and inhibit mtDNA-triggered cGAS/STING inflammation in osteoarthritis.
Li T · Bioactive materials · 2026
Not a test of Elamipretide (SS-31) alone · 8 results
- Chondrocyte membrane-camouflaged selenium nanoplatform with dual targeting for mitochondrial restoration and osteoarthritis therapy.
Zhang Z · Journal of controlled release : official journal of the Controlled Release Society · 2026
Not a test of Elamipretide (SS-31) alone · 8 results
- Dual-stabilized selenium nanoparticles with chitosan and SS31 peptide: Resolving instability for enhancing ROS elimination, suppressing inflammation, and combating bacterial infections.
Ming P · Colloids and surfaces. B, Biointerfaces · 2025
Not a test of Elamipretide (SS-31) alone · 7 results
- Synergistic mitochondrial homeostasis regulation and cholinergic circuits reconstruction via a one-step synthesized multifunctional hydrogel facilitates spinal cord injury repair.
Luo Y · Bioactive materials · 2026
Not a test of Elamipretide (SS-31) alone · 7 results
- Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.
Yin X · Human molecular genetics · 2016
Not a test of Elamipretide (SS-31) alone · 6 results
- Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer's Disease.
Qian K · ACS nano · 2022
Not a test of Elamipretide (SS-31) alone · 12 results
- Synthetic nanoparticles functionalized with cell membrane-mimicking, bone-targeting, and ROS-controlled release agents for osteoporosis treatment.
Zhang W · Journal of controlled release : official journal of the Controlled Release Society · 2025
Not a test of Elamipretide (SS-31) alone · 6 results
- Acute myocardial infarction therapy using calycosin and tanshinone co-loaded; mitochondrion-targeted tetrapeptide and cyclic arginyl-glycyl-aspartic acid peptide co-modified lipid-polymer hybrid nano-system: preparation, characterization, and anti myocardial infarction activity assessment.
Yan J · Drug delivery · 2022
Not a test of Elamipretide (SS-31) alone · 6 results
- Protective Effect of Mitochondria-Targeted Polydopamine Nanoparticles in Alleviating Hepatic Ischemia-Reperfusion Injury.
Huang Y · ACS nano · 2026
Not a test of Elamipretide (SS-31) alone · 6 results
- Antioxidant-Enhanced Nanoparticles Delay the Progression of Osteoarthritis.
Shen C · ACS omega · 2025
Not a test of Elamipretide (SS-31) alone · 6 results
- Double-network hydrogel enhanced by SS31-loaded mesoporous polydopamine nanoparticles: Symphonic collaboration of near-infrared photothermal antibacterial effect and mitochondrial maintenance for full-thickness wound healing in diabetes mellitus.
Deng QS · Bioactive materials · 2023
Not a test of Elamipretide (SS-31) alone · 5 results
- The Mitochondria-Targeted Micelle Inhibits Alzheimer's Disease Progression by Alleviating Neuronal Mitochondrial Dysfunction and Neuroinflammation.
Qian W · Small (Weinheim an der Bergstrasse, Germany) · 2025
Not a test of Elamipretide (SS-31) alone · 5 results
- Oxidative stress promotes ventilator-induced lung injury through activating NLRP3 inflammasome and TRPM2 channel.
An X · Artificial cells, nanomedicine, and biotechnology · 2019
Not a test of Elamipretide (SS-31) alone · 5 results
- Doxorubicin-Loaded Liposome with the Function of "Killing Two Birds with One Stone" against Glioma.
Cen J · ACS applied materials & interfaces · 2023
Not a test of Elamipretide (SS-31) alone · 5 results
- An SS31-rapamycin conjugate via RBC hitchhiking for reversing acute kidney injury.
Yu B · Biomaterials · 2023
Not a test of Elamipretide (SS-31) alone · 5 results
- Acid-Triggered Cascaded Responsive Supramolecular Peptide Alleviates Myocardial Ischemia‒Reperfusion Injury by Restoring Redox Homeostasis and Protecting Mitochondrial Function.
Liao X · Advanced healthcare materials · 2025
Not a test of Elamipretide (SS-31) alone · 5 results
- Polyphosphate- and Antioxidant Peptide-Based Coacervate Delivers miRNA.
Wang C · ACS applied materials & interfaces · 2025
Not a test of Elamipretide (SS-31) alone · 5 results
- Rational fusion design inspired by cell-penetrating peptide: SS31/S-14 G Humanin hybrid peptide with amplified multimodal efficacy and bio-permeability for the treatment of Alzheimer's disease.
Qian K · Asian journal of pharmaceutical sciences · 2024
Not a test of Elamipretide (SS-31) alone · 12 results
- Engineered Mitochondria-Targeted Biomimetic Hybrid Nanovesicles Ameliorate Rheumatoid Arthritis via Regulating Macrophage Autophagy and cGAS-STING Signaling.
Lu L · ACS applied materials & interfaces · 2026
Not a test of Elamipretide (SS-31) alone · 5 results
- ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule.
Liu D · Science advances · 2020
Not a test of Elamipretide (SS-31) alone · 4 results
- A ROS-Responsive Liposomal Composite Hydrogel Integrating Improved Mitochondrial Function and Pro-Angiogenesis for Efficient Treatment of Myocardial Infarction.
Zheng Z · Advanced healthcare materials · 2022
Not a test of Elamipretide (SS-31) alone · 4 results
- Targeted Delivery of AGO-2 to Myocardial Mitochondria via Functionalized Nanoparticles Attenuates Oxidative Stress in Diabetic Cardiomyopathy.
Du W · ACS applied materials & interfaces · 2025
Not a test of Elamipretide (SS-31) alone · 4 results
- Peptide Power: Mechanistic Insights into the Effect of Mitochondria-Targeted Tetrapeptides on Membrane Electrostatics from Molecular Simulations.
Tamucci JD · Molecular pharmaceutics · 2023
Not a test of Elamipretide (SS-31) alone · 4 results
- Preparation of Targeted Mitochondrion Nanoscale-Release Peptides and Their Efficiency on Eukaryotic Cells.
He Y · Journal of biomedical nanotechnology · 2021
Not a test of Elamipretide (SS-31) alone · 4 results
- Mitochondria-Targeted Liposomes Boost Thermogenesis for Adipose Tissue Regulation.
Tian S · Advanced healthcare materials · 2026
Not a test of Elamipretide (SS-31) alone · 4 results
- Topology-Controlled PEGylation Enhances Renal Accumulation of Therapeutic Peptide for Treating Ischemia-Reperfusion Injury.
Wen Y · Nano letters · 2026
Not a test of Elamipretide (SS-31) alone · 4 results
- A Polytherapy Intervention in an Experimental Traumatic Optic Neuropathy Mouse Model.
Tse DT · Ophthalmic plastic and reconstructive surgery · 2025
Not a test of Elamipretide (SS-31) alone · 4 results
- Reactive oxygen species regulation of autophagy in skeletal muscles.
Rahman M · Antioxidants & redox signaling · 2014
Not a test of Elamipretide (SS-31) alone · 3 results
- Reprogramming of Treg cell-derived small extracellular vesicles effectively prevents intestinal inflammation from PANoptosis by blocking mitochondrial oxidative stress.
Gong W · Trends in biotechnology · 2025
Not a test of Elamipretide (SS-31) alone · 3 results
- Mitochondrion-targeted carboxymethyl chitosan hybrid nanoparticles loaded with Coenzyme Q10 protect cardiac grafts against cold ischaemia‒reperfusion injury in heart transplantation.
Yuan S · Journal of translational medicine · 2023
Not a test of Elamipretide (SS-31) alone · 3 results
- Microenvironment Remodeling Microgel Repairs Degenerated Intervertebral Disc via Programmed Delivery of MicroRNA-155.
Guo C · ACS applied materials & interfaces · 2025
Not a test of Elamipretide (SS-31) alone · 3 results
- Energy-replenishing, mitochondria-targeted hydrogel microspheres mitigate sarcopenia via cellular senescence amelioration.
Bao W · Journal of controlled release : official journal of the Controlled Release Society · 2026
Not a test of Elamipretide (SS-31) alone · 3 results
- Natural Vitamins and Novel Synthetic Antioxidants Targeting Mitochondria in Cognitive Health: A Scoping Review of In Vivo Evidence.
Squillace A · Antioxidants (Basel, Switzerland) · 2026
Not a test of Elamipretide (SS-31) alone · 3 results
- A Caspase-3 responsive nanoemulsion for targeted treatment of rheumatoid arthritis through dual modulation of inflammation and mitochondrial dysfunction.
Zhang J · Colloids and surfaces. B, Biointerfaces · 2025
Not a test of Elamipretide (SS-31) alone · 3 results
- Mitochondria-Targeted Peptides and Bilayer Composition Modulate Membrane Electroporation under Elevated Electrochemical Stress.
Tamucci JD · Langmuir : the ACS journal of surfaces and colloids · 2025
Not a test of Elamipretide (SS-31) alone · 3 results
- Early targets and progressive deterioration in cardiac performance in response to chronically modified cardiac troponin I.
Ravichandran VS · American journal of physiology. Heart and circulatory physiology · 2026
Not a test of Elamipretide (SS-31) alone · 3 results